Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dw-224a
1. 1-cyclopropyl-6-fluoro-7-[(8e)-8-methoxyimino-2,6-diazaspiro[3.4]octan-6-yl]-4-oxo-1,8-naphthyridine-3-carboxylic Acid
2. (e)-1-cyclopropyl-6-fluoro-7-(8-(methoxyimino)-2,6-diazaspiro[3.4]octan-6-yl)-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid
3. Schembl13246549
4. Tqp0864
5. Db12479
| Molecular Weight | 401.4 g/mol |
|---|---|
| Molecular Formula | C19H20FN5O4 |
| XLogP3 | -0.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 4 |
| Exact Mass | 401.14993230 g/mol |
| Monoisotopic Mass | 401.14993230 g/mol |
| Topological Polar Surface Area | 107 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 794 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Zabofloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zabofloxacin, including repackagers and relabelers. The FDA regulates Zabofloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zabofloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Zabofloxacin supplier is an individual or a company that provides Zabofloxacin active pharmaceutical ingredient (API) or Zabofloxacin finished formulations upon request. The Zabofloxacin suppliers may include Zabofloxacin API manufacturers, exporters, distributors and traders.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zabofloxacin Drug Master File in Korea (Zabofloxacin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zabofloxacin. The MFDS reviews the Zabofloxacin KDMF as part of the drug registration process and uses the information provided in the Zabofloxacin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zabofloxacin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zabofloxacin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zabofloxacin suppliers with KDMF on PharmaCompass.
Zabofloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zabofloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zabofloxacin GMP manufacturer or Zabofloxacin GMP API supplier for your needs.
A Zabofloxacin CoA (Certificate of Analysis) is a formal document that attests to Zabofloxacin's compliance with Zabofloxacin specifications and serves as a tool for batch-level quality control.
Zabofloxacin CoA mostly includes findings from lab analyses of a specific batch. For each Zabofloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zabofloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Zabofloxacin EP), Zabofloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zabofloxacin USP).
LOOKING FOR A SUPPLIER?
